LONDON, October 22 /PRNewswire/ -- Diabetic Hypoglycaemia (http://www.hypodiab.com), the influential online diabetes journal published by ESP Bioscience, leads its new issue with a topical editorial, authored by Professor Simon Heller, one of the ADVANCE investigators, and Dr Rory McCrimmon. The impact of intensive lowering of blood glucose levels on cardiac mortality was studied in the ACCORD and ADVANCE trials, and the outcomes of these trials suggested very different conclusions. Results from the ACCORD trial certainly suggest that aggressive lowering of blood glucose using multiple therapies to target an HbA1c of 6% or below is unsafe in some patients with type 2 diabetes; the trial was terminated due to an unexpected increase in the number of sudden cardiac deaths.

REDMOND, Washington and LANGLEY, England, October 22 /PRNewswire/ --

Microsoft Corp. and Travelport today announced they are teaming together to develop an integrated set of services targeted for the travel industry to address challenges faced by travellers, suppliers, and travel agents. Through the collaboration, Microsoft and Travelport will explore the development of services designed to improve the traveller experience and to provide airlines, travel suppliers, and travel agencies, including travel management companies (TMCs) and online travel agents (OTAs), with new revenue and cost reduction opportunities, broader distribution reach, and improved customer satisfaction and loyalty. The services are slated for Q1 2009.

LONDON, October 22 /PRNewswire/ -- A new and exciting site for online shopping has just opened its doors for business in the UK. Funkbet.com allows customers to find fantastic opportunities to buy the latest and greatest products 80-90% below the normal retail price.

The shoppers can achieve this by competing against other shoppers to find the lowest unique bid for the product on offer. This is exactly the opposite of the more famous auctions sites, like eBay.com where the products go to the highest bidder.

COPENHAGEN, October 22 /PRNewswire/ -- Breakthrough: Results from the fourth year in a long-term clinical study prove the disease modifying effect of GRAZAX(R). For the first time ever, it is documented that the positive clinical effect of the tablet vaccine persists after completion of treatment.

Today, ALK announces main results from the first follow-up year in a long-term study (GT-08) with GRAZAX(R), the company's tablet-based vaccine against grass pollen allergy. The clinical study documents that the effect of GRAZAX(R) persists following completion of the recommended three-year treatment regimen. Furthermore, blood samples from patients show a persistent, positive effect on the immune system indicating a lasting tolerance to grass pollen.

INGELHEIM, Germany, October 22 /PRNewswire/ --

- BI 6727, a Highly Potent and Selective Plk1 inhibitor, Represents Latest Advance in Company's Plk1 Programme

- For non-US Healthcare Media

LONDON, October 22 /PRNewswire/ --

- Unite Survey Reveals Longer Waiting Times and Stressed Workforce

The speech and language therapy service is 'heading towards crisis', a new survey of the profession by Unite, the largest union in the country, has revealed.

Unite, which represents 5,500 speech and language therapists (SALTS) and SALT assistants, said that this means longer waiting and referral times for patients and clients, while the workforce becomes more stressed and demoralised.

Unite's Lead Officer for SALT members, Fiona Farmer said: 'The survey of our reps paints a service heading towards crisis, with our members having to introduce priority lists and preside over a decline in specialist services.'

PORTON DOWN, England, October 22 /PRNewswire/ --

Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today that it has signed a third licence agreement with Applied Biosystems.

The licence provides Enigma with access to claims of US Patent No. 5,928,907 that describe methods for monitoring nucleic acid amplification in real-time. This is the first such licence Applied Biosystems has granted to the method claims of the '907 patent.

This complements Enigma's existing licence under certain patents owned by Applied Biosystems for real-time PCR thermal cyclers.

Financial terms were not disclosed.

WALTHAM, Massachusetts, October 22 /PRNewswire/ --

- Significant Unmet Need Remains for Agents that are Effective in Treating Triple-Negative Breast Cancer, According to a New Report from Decision Resources

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that significant market penetration will drive Genentech/Roche/Chugai's Avastin to garner just over 20 percent of total sales in the breast cancer drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan in 2017.

PARIS, October 22 /PRNewswire/ --

South Korean-based SK Engineering and Construction (SKEC) is using Quadrem solutions to manage sourcing and procurement communications with an international community of 5,000 suppliers. Approximately 300 to 400 tenders are expected to be issued by SKEC to support a gas train project it's undertaking in the Middle East for a national petroleum company.

We chose Quadrem to handle Web-based sourcing and procurement for this USD $2 billion project because we must provide excellent management of worldwide suppliers, said Mr. Oh-Young LEE, Project Procurement Chief Manager of the Fourth Gas Train Project Team, SKEC.

COPENHAGEN, Denmark, October 22 /PRNewswire/ -- Zecure, a leading provider of e-commerce fraud prevention solutions, today announced that OrbitalPay, LLC has installed its award-winning Acquirer SAFE suite to prevent fraudulent merchants from hiding illegal transactions and to keep high risk merchants under control.

Acquirer SAFE helps Acquiring Banks and Payment Service Providers (PSPs) keep high-risk merchants under control and prevent them from processing illegal transactions disguised as legitimate ones. Acquirer SAFE enables acquirers and PSPs to identify a transaction's true origin based on the behavior of shoppers on the merchant's website.